The guidelines warn, however, that GLP-1 receptor agonist therapy is not indicated for all patients and should be used with caution in patients with a history of significant gastrointestinal disease, such as a diagnosis of gastroparesis, due to a possible exacerbation of the condition with incretin mimetic therapy
Pick Henry Meds if semaglutide is your clear choice, you want to start this week, and you weigh proactive nausea support over pharmacy-partner provenance
30 Also, the onset of acute pancreatitis occurred after 12 months in the LEADER trial and after more than five to six months in the SCALE trial, indicating that the likelihood of developing pancreatitis was influenced more by the rate and degree of weight loss than the drug itself
What to Know About Retatrutide
Diarrhea and Constipation Some patients develop diarrhea , while others experience constipation due to changes in digestive motility
What if I want to stop GLP-1 drugs completely